CHECKPOINT CAPITAL L.P.

PrivateCIK: 1977548
Location

SAN FRANCISCO, CA

πŸ“‹ What this filing means

CHECKPOINT CAPITAL L.P. filed this quarterly 13F‑HR report disclosing 18 equity positions with a total reported market value of $165.10M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.

18
Positions
$165.10M
Total AUM (reported)
8.30M
Total Shares

Allocation by class

TOTAL AUM$165.10M18 positions
COM$78.99M47.8%
SPONSORED ADR$31.22M18.9%
COM NEW$21.32M12.9%
UNIT$16.07M9.7%
COM CL A$15.79M9.6%
ORDINARY SHARES$1.70M1.0%

Portfolio Concentration

Top 348.1%4–1045.0%11–256.9%TOP 1093.1%0%100%
Top 3$79.39M48.1%
4–10$74.24M45.0%
11–25$11.47M6.9%

Top 3 weight

48.1%

Top 10 weight

93.1%

Voting Authority Distribution

Total shares with voting rights: 8.30M

Sole

Full voting authority

7.62M

shares

% of voting shares91.8%
Shared

Joint voting authority

0.00

shares

% of voting shares0.0%
None

No voting authority

680K

shares

% of voting shares8.2%

Investment Discretion (by position count)

Sole18
Shared0
Other0
Dominant voting typeSole Β· 91.8% of voting shares
Institutional Holdings18
Rows:

RHYTHM PHARMACEUTICALS INC

SOLE
COM
Shares730K
TypeSH
Market value$33.56M
20.33%
Sole
730K
Shared
0.00
None
0.00

ARGENX SE

SOLE
SPONSORED ADR
Shares70K
TypeSH
Market value$26.63M
16.13%
Sole
70K
Shared
0.00
None
0.00

CYTOKINETICS INC

SOLE
COM NEW
Shares230K
TypeSH
Market value$19.20M
11.63%
Sole
230K
Shared
0.00
None
0.00

SPDR BIOTECH ETF TR

SOLE
UNIT
Shares180K
TypeSH
Market value$16.07M
9.73%
Sole
0.00
Shared
0.00
None
180K

IRONWOOD PHARMACEUTICALS INC

SOLE
COM CL A
Shares1.38M
TypeSH
Market value$15.79M
9.56%
Sole
880K
Shared
0.00
None
500K

SPRINGWORKS THERAPEUTICS INC

SOLE
COM
Shares340K
TypeSH
Market value$12.41M
7.52%
Sole
340K
Shared
0.00
None
0.00

AXSOME THERAPEUTICS INC

SOLE
COM
Shares155.35K
TypeSH
Market value$12.36M
7.49%
Sole
155.35K
Shared
0.00
None
0.00

MIRUM PHARMACEUTICALS INC

SOLE
COM
Shares233.66K
TypeSH
Market value$6.90M
4.18%
Sole
233.66K
Shared
0.00
None
0.00

PROTAGONIST THERAPEUTICS INC

SOLE
COM
Shares266.86K
TypeSH
Market value$6.12M
3.71%
Sole
266.86K
Shared
0.00
None
0.00

AVADEL PHARMACEUTICALS PLC

SOLE
SPONSORED ADR
Shares325K
TypeSH
Market value$4.59M
2.78%
Sole
325K
Shared
0.00
None
0.00

PHATHOM PHARMACEUTICALS INC

SOLE
COM
Shares359.45K
TypeSH
Market value$3.28M
1.99%
Sole
359.45K
Shared
0.00
None
0.00

ATYR PHARMA INC

SOLE
COM NEW
Shares1.50M
TypeSH
Market value$2.12M
1.28%
Sole
1.50M
Shared
0.00
None
0.00

TREVI THERAPEUTICS INC

SOLE
COM
Shares1.29M
TypeSH
Market value$1.73M
1.05%
Sole
1.29M
Shared
0.00
None
0.00

GH RESEARCH PLC

SOLE
ORDINARY SHARES
Shares293.94K
TypeSH
Market value$1.70M
1.03%
Sole
293.94K
Shared
0.00
None
0.00

ALLAKOS INC

SOLE
COM
Shares444.80K
TypeSH
Market value$1.21M
0.74%
Sole
444.80K
Shared
0.00
None
0.00

DISC MEDICINE INC

SOLE
COM
Shares10K
TypeSH
Market value$577.6K
0.35%
Sole
10K
Shared
0.00
None
0.00

ACLARIS THERAPEUTICS INC

SOLE
COM
Shares453.61K
TypeSH
Market value$476.3K
0.29%
Sole
453.61K
Shared
0.00
None
0.00

EDGEWISE THERAPEUTICS INC

SOLE
COM
Shares33K
TypeSH
Market value$361.0K
0.22%
Sole
33K
Shared
0.00
None
0.00
CHECKPOINT CAPITAL L.P. 13F Holdings β€” 18 Positions | Finecho